Analysis by the Office of Assemblyman So Byunghoon, Democratic Party

Medical device adverse events up 50% compared to 2021

Implantable devices account for 73%... "Urgent investigation needed for recurring and serious cases"

Reports of 'serious adverse events' involving medical devices—such as hospitalization, functional deterioration, life-threatening situations, or death—have more than doubled in the past five years. The rate of increase was more than twice as fast as that of all medical device adverse event reports.


Serious Medical Device Adverse Events Double in Five Years... Surge Concentrated in Breast Implants View original image

According to data submitted by the Ministry of Food and Drug Safety to Assemblyman So Byung-hoon of the National Assembly's Health and Welfare Committee on September 21, a total of 9,104 medical device adverse events were reported in Korea from 2021 to 2025.


Broken down by year, the number steadily increased from 1,482 cases in 2021 to 1,513 in 2022, 1,900 in 2023, 1,983 in 2024, and 2,226 in 2025—an increase of 50.2% over the five-year period. By risk class, adverse events involving Class IV medical devices, categorized as "devices with the highest risk," accounted for 6,383 cases, or 70.1% of the total during the same period.


Serious adverse events numbered 3,011, making up 33.1% of all reports. These increased by 120.6%, from 389 cases in 2021 to 858 cases in 2025, significantly outpacing the overall growth rate of adverse event reports (50.2%) over the same span.


Of the serious adverse events, hospitalizations or extensions of hospitalization made up the vast majority with 2,998 cases. There were 8 cases where adverse events led to death or posed a life-threatening risk, and 5 cases involved irreversible or severe disability or functional loss.


Adverse events were particularly concentrated among implantable medical devices that are used in the body for extended periods. In the past five years, 6,667 adverse events were related to implantable medical devices, accounting for 73.2% of all reports. Of these, silicone gel breast implants were linked to 5,749 cases and silicone shell breast implants to 277 cases. Combined, adverse events involving breast implants totaled 6,026, which represents 90.4% of all reports for implantable devices.


Serious Medical Device Adverse Events Double in Five Years... Surge Concentrated in Breast Implants View original image

The Ministry of Food and Drug Safety explained that the number of adverse event reports does not immediately indicate a confirmed causal link between the medical device and device defect or harm to the patient. This is because the reports are based on cases recognized by medical device handlers.


The ministry analyzes and evaluates reported adverse events, and if necessary, conducts causality investigations and safety actions. However, there is no legally mandated processing period for these investigations, so they typically take 3 to 4 months, and may take longer depending on factors such as response times from overseas manufacturers or securing patient medical records. Over the past five years, the ministry took 13 regulatory actions involving changes to approval conditions and issued 14 safety notices.



Assemblyman So pointed out, "While the number of reports alone cannot conclusively determine device defects or causality, the fact that serious adverse events have doubled in the past five years underscores the urgent need to promptly identify causes, particularly for recurring or severe cases." He continued, "Transparency must be enhanced so that the public can access the findings of investigations and details of safety actions. Since over 70% of adverse events involve implantable medical devices used long-term in the body, it is imperative to continuously scrutinize whether post-market safety management systems, such as long-term follow-up studies and patient notification frameworks, actually result in meaningful patient protection."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing